首页 / 院系成果 / 成果详情页

RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells  期刊论文  

  • 编号:
    0add0314-57cc-4968-97b1-b3510228036d
  • 作者:
  • 语种:
    英文
  • 期刊:
    BIOTECHNOLOGY LETTERS ISSN:0141-5492 2017 年 39 卷 9 期 (1359 - 1367) ; SEP
  • 收录:
  • 关键词:
  • 摘要:

    To investigate the roles of Dead end 1 (Dnd1) in modulating cancer stem cell-related traits of hepatocellular carcinoma (HCC).
    Dead end (Dnd1) inhibited spheroid formation, suppressed the expression of stemness-related genes, and increased sensitivity to sorafenib in HCC cells. Mechanistically, Dnd1 could bind to 3'-UTR of LATS2, the key kinase of Hippo pathway, thus elevating LATS2 mRNA stability and its expression, subsequently leading to phosphorylation of YAP and its cytoplasmic retention. As a result, epithelial-mesenchymal transition (EMT) was weakened and therefore the generation of HCC stem cell properties was suppressed.
    Dnd1 functions as a tumor suppressor by prohibiting CSC-like characteristics via activating Hippo pathway in HCC cells. Dnd1 could thus be a novel therapeutic target for HCC patients.

  • 推荐引用方式
    GB/T 7714:
    Xu Weiling,Gong Fangchao,Zhang Ting, et al. RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells [J].BIOTECHNOLOGY LETTERS,2017,39(9):1359-1367.
  • APA:
    Xu Weiling,Gong Fangchao,Zhang Ting,Chi Baorong,&Wang Jingyu.(2017).RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells .BIOTECHNOLOGY LETTERS,39(9):1359-1367.
  • MLA:
    Xu Weiling, et al. "RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells" .BIOTECHNOLOGY LETTERS 39,9(2017):1359-1367.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:57 下载次数:0
浏览次数:57
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部